Form 8-K - Current report:
SEC Accession No. 0001558370-23-015961
Filing Date
2023-09-25
Accepted
2023-09-25 08:00:26
Documents
14
Period of Report
2023-09-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hrmy-20230921x8k.htm   iXBRL 8-K 45286
2 EX-10.1 hrmy-20230921xex10d1.htm EX-10.1 55970
3 GRAPHIC hrmy-20230921x8k001.jpg GRAPHIC 1167
  Complete submission text file 0001558370-23-015961.txt   236325

Data Files

Seq Description Document Type Size
4 EX-101.SCH hrmy-20230921.xsd EX-101.SCH 3162
5 EX-101.LAB hrmy-20230921_lab.xml EX-101.LAB 15927
6 EX-101.PRE hrmy-20230921_pre.xml EX-101.PRE 10080
8 EXTRACTED XBRL INSTANCE DOCUMENT hrmy-20230921x8k_htm.xml XML 4879
Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Filer) CIK: 0001802665 (see all company filings)

EIN.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39450 | Film No.: 231273147
SIC: 2834 Pharmaceutical Preparations